Interim CEO Meni Morim says the three individuals bring a wealth of ‘history and operational...
Featured articles
Its lead asset, RXC004, is part of a potentially breakthrough group of cancer drugs called...
Here we take a closer look at healthcare investor NetScientific PLC (LON:NSCI)
Zepto will be used in one of the top clinics in Canada, where more than 10,000 cataract...
Here we take a closer look at Genedrive PLC (LON:GDR)
Also on the move were ICC International Cannabis, Tilray, Codebase Ventures, Golden Leaf...
Featured companies
ChemioCare is a pharmaceutical company working on a proprietary transdermal delivery platform....
Cancer remains one of the world’s most significant diseases. A key challenge in the fight agai...
Clinigen Group plc is a rapidly-growing global pharmaceutical and services company with a uniq...
Circassia is a specialty pharmaceutical company focused on respiratory disease. Our growing co...
Tumour Trace is dedicated to developing innovative, patented cancer screening and diagnostic t...
Avacta’s principal focus is on its proprietary Affimer® platform, a novel engineered alternati...
Global biotech Newswire
As part of the deal, Wayland will ink a three-year supply agreement with ICC to supply it with...
The Cincinnati-based health and wellness company will use the proceeds as general working capital
The biopharmaceutical company is cutting 82 positions, roughly 37% of its workforce
Interim CEO Meni Morim says the three individuals bring a wealth of ‘history and operational...
Its lead asset, RXC004, is part of a potentially breakthrough group of cancer drugs called...
Yrjö Wichmann is stepping down as CFO to become Faron’s new Vice President, Financing and...
The drug developer is assessing the best route forward for its lead drug, a treatment for the...
Here we take a closer look at healthcare investor NetScientific PLC (LON:NSCI)
The firm said it is officially changing its corporate name to True Leaf Brands Inc, effective...
Executive video interviews
GSRX Industries (OTCQB:GSRX) Executive Chairman Christian Briggs joined Steve Darling...
Motif Bio PLC's (LON:MTFB) Graham Lumsden chats to Proactive London's Andrew Scott after...
Buds today are Namaste Technologies Inc (CVE:N) (OTCMKTS:NXTTF), ICC...
Lancor Scientific's Roland Schlesinger updates Proactive London's Andrew Scott on latest...
IXICO PLC's (LON:IXI) CEO Giulio Cerroni talks Proactive London's Andrew Scott through...
Jamal Rushdy and Hilary Spence from Collagen Solutions PLC (LON:COS) speak to Proactive...
Invitrocue Ltd (ASX:IVQ) chief executive officer Steven Fang speaks to Proactive...
Moleculin Biotech (NASDAQ: MBRX) Founder, President and CEO Walter Klemp sat down with...
True Leaf Medicine (CSE: MJ-OTCQX: TRLFF) CEO Darcy Bomford sat down with Steve Darling...
Concepta PLC (LON:CPTA) chairman Matthew Walls spoke to Proactive London's Andrew Scott...
WideCells Group PLC's (LON:WDC) David Sefton and John Quinlan update Proactive London's...
CytoDyn (OTCQB:CYDY) CEO Nader Pourhassan joined Steve Darling from Proactive Investors...
Big picture investment ideas in Biotech Capital
Its lead asset, RXC004, is part of a potentially breakthrough group of cancer drugs called...
Here we take a closer look at healthcare investor NetScientific PLC (LON:NSCI)
Here we take a closer look at Genedrive PLC (LON:GDR)
Here we take a closer look at Integumen PLC (LON:SKIN), which has developed and digitised an...
We take a closer look at Collagen Solutions, which received third-party validation of its...
Here we take a closer look at Scancell, which is at the vanguard of immuno-oncology
The New Jersey company's lead product is Twirla, a low-dose prescription contraceptive applied...
Here we take a closer look at testing firm Concepta PLC (LON:CPT)
Here we take a closer look at Midatech Pharma PLC (LON:MTPH)
Capital Network Research
Shield Therapeutics PLC Heading for a US approval decision
May 09 2019
Shield Therapeutics (LON:STX) is making excellent progress having...
Avacta - interim results confirm progress
April 09 2019
Avacta Group PLC (LON:AVCT) reported interim results to...
Judges Scientific's focus is paying dividends
April 04 2019
Judges Scientific PLC (LON:JDG) posted strong 2018 full year...
Shield Therapeutics PLC - Feraccru: a potential game changer in the...
January 18 2019
Feraccru is a unique, non-salt, formulation oral iron: strong...
Avacta Group - Maximising Affimer's potential across therapeutics and...
October 03 2018
Over the last year or so, management has delivered significant progress in bringing their...
Judges Scientific PLC - 2018 Interim Results
September 21 2018
Judges Scientific reported results for the first half of 2018. The period included a...
Partners:
